• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 期刊论文
  5. Chimeric antigen receptor-engineered T-cell therapy for liver cancer

Chimeric antigen receptor-engineered T-cell therapy for liver cancer

来源 :国际肝胆胰疾病杂志：英文版 | 被引量 : 0次 | 上传用户：peterpan984
【摘 要】
：
Background:Chimeric antigen receptor-engineered T-cell(CAR-T)therapy is a newly developed immunotherapy used in the treatment of cancers.Because CAR-T therapy h
【作 者】
：
Yang Chen Chang-Yong E Zhi-Wen 
【机 构】
：
DepartmentofHepatobiliaryandPancreasSurgery,DepartmentofHepatobiliaryandPancreaticSurgery
【出 处】
：
国际肝胆胰疾病杂志：英文版
【发表日期】
：
2018年4期
【关键词】
：
Liver cancer CHIMERIC ANTIGEN receptor-engineered T-CELL THERAPY Immunotherapy T 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Chimeric antigen receptor-engineered T-cell(CAR-T)therapy is a newly developed immunotherapy used in the treatment of cancers.Because CAR-T therapy has shown great success in treating CD19-positive hematological malignancies,its application has
其他文献
Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure
Background:Hepatitis B virus(HBV)-associated acute-on-chronic liver failure(HBV-ACLF)is a lifethreatening condition and its exact pathophysiology and progressio
期刊
MicroRNAHEPATITISBVIRUSAcute-on-chronicliverFAILUREPROGNOSIS
Liver transplantation benefits selected patients with hilar cholangiocarcinoma and colorectal liver
Hilar cholangiocarcinoma(HCCA)is an aggressive malignancy with a dismal prognosis.The 5-year survival rate has been reported to range from 39%to 50%if an R0 res
期刊
HILARcholangiocarcinoma(HCCA)AmongUNRESECTABLEPATIENTS
Glissonian approach combined with major hepatic vein first for laparoscopic anatomic hepatectomy
Background:Laparoscopic anatomic hepatectomy remains challenging because of the complex interior structures of the liver.Our novel strategy includes the Glisson
期刊
HEPATECTOMYLAPAROSCOPYLiverdiseasesSurgicalproceduresMAJORhepaticVEIN
Prediction of rat liver transplantation outcomes using energy metabolites measured by microdialysis
Background:Warm ischemia jeopardizes graft quality and recipient survival in donation after cardiac death(DCD)transplantation.Currently,there is no system to ob
期刊
EnergyMETABOLITESGRAFTevaluationWARMISCHEMIAMICRODIALYSISDONATIONafterc
Should we invariably follow the current guidelines to treat our HCC patients?
To the Editor: We read with great interest the article by Dr. Vitale et al.[1], which developed an ITA.LI.CA scoring system to improve the prognostic utility fo
期刊
EDITORsystemCOMMENTS
Machine perfusion for liver transplantation:A concise review of clinical trials
Background:With the increased use of extended-criteria donors,static cold storage has failed to provide optimal preservation of liver grafts,resulting in early
期刊
LiverTRANSPLANTATIONMachinePERFUSIONDONATIONaftercirculatoryDEATH
17-beta-hydroxysteroid dehydrogenase 13 inhibits the progression andrecurrence of hepatocellular car
期刊
脱氢酶癌HCCHepatocellular carcinomaHSD17B13ProgressionRecurrenceTumor suppres
IL-26 and the prognosis of hepatocellular carcinoma after resection
To the Editor: I read with interest the article by Xi et al. that IL-26 is a novel prognostic factor for hepatocellular carcinoma (HCC) after resection [1]. I h
期刊
HEPATOCELLULARCARCINOMA(HCC)IL-26PROGNOSIS
Assessment of clinical outcomes of advanced hilar cholangiocarcinoma
Background:Low resectability and poor survival outcome are common for hilar cholangiocarcinoma(HCCA),especially in advanced stages.The present study was to asse
期刊
HILARCHOLANGIOCARCINOMAHepaticarteryRESECTIONPREOPERATIVEBILIARYdrainage
Food for thought on hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a serious public health problem worldwide [1]. Recently, Chen et al.[2] reported the observed survival and relative survival o
期刊
HEPATOCELLULARcarcinoma(HCC)PUBLIChealthproblemWORLDWIDE